Evidence map›Paper›PMID 9851392›Full record

ArticleLancet (London, England)1998

Increased thrombotic vascular events after change of statin.

M Thomas, J Mann

Registry-linked trialAbstract readComparative StudyLetter
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01770210 (A Multicenter, Open-label, 30-week Observational Clinical Study to Examine the Progress of Patients After Leaving the Cardiology Clinic or Unit Due to Acute Cardiovascular Event.), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01770210 completedstarted 2013, after this paper: background citation

A Multicenter, Open-label, 30-week Observational Clinical Study to Examine the Progress of Patients After Leaving the Cardiology Clinic or Unit Due to Acute Cardiovascular Event.

Ran2013Enrolled670Registered outcomes6Posted comparisons0ConditionsCardiovascular DisordersArmsPatients on atorvastatin treatment
Open the trial in the graph
3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. The influence of statin withdrawal and adherence on stroke outcomes.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  3. Effect of pharmaceutical regulatory policy on health impact.British journal of clinical pharmacology · 2020
    Article
  4. Observational
  5. Drug discontinuation effects are part of the pharmacology of a drug.The Journal of pharmacology and experimental therapeutics · 2011
    Article
  6. Practical use of the Framingham risk score in primary prevention: Canadian perspective.Canadian family physician Medecin de famille canadien · 2011
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Reference drug programs: effectiveness and policy implications.Health policy (Amsterdam, Netherlands) · 2007
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Current trends in the cardiovascular clinical trial arena (I).Current controlled trials in cardiovascular medicine · 2004
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

M Thomas
J Mann

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anticholesteremic AgentsCholesterol, LDLDrug CostsFatty Acids, MonounsaturatedFluvastatinHumansIndolesSimvastatinThrombosisTriglyceridesAnticholesteremic AgentsCholesterol, LDLFatty Acids, MonounsaturatedFluvastatinIndolesSimvastatinTriglycerides

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.